vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $124.5M, roughly 1.7× PagerDuty, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs 2.7%, a 127.1% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 4.7%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 5.9%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.

IRTC vs PD — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.7× larger
IRTC
$208.9M
$124.5M
PD
Growing faster (revenue YoY)
IRTC
IRTC
+22.4% gap
IRTC
27.1%
4.7%
PD
Higher net margin
PD
PD
127.1% more per $
PD
129.7%
2.7%
IRTC
More free cash flow
PD
PD
$9.6M more FCF
PD
$24.1M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
5.9%
PD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IRTC
IRTC
PD
PD
Revenue
$208.9M
$124.5M
Net Profit
$5.6M
$161.6M
Gross Margin
70.9%
85.3%
Operating Margin
1.1%
6.5%
Net Margin
2.7%
129.7%
Revenue YoY
27.1%
4.7%
Net Profit YoY
518.5%
2827.7%
EPS (diluted)
$0.18
$1.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
PD
PD
Q4 25
$208.9M
$124.5M
Q3 25
$192.9M
$123.4M
Q2 25
$186.7M
$119.8M
Q1 25
$158.7M
$121.4M
Q4 24
$164.3M
$118.9M
Q3 24
$147.5M
$115.9M
Q2 24
$148.0M
$111.2M
Q1 24
$131.9M
$111.1M
Net Profit
IRTC
IRTC
PD
PD
Q4 25
$5.6M
$161.6M
Q3 25
$-5.2M
$9.6M
Q2 25
$-14.2M
$-7.2M
Q1 25
$-30.7M
$-8.8M
Q4 24
$-1.3M
$-5.9M
Q3 24
$-46.2M
$-10.9M
Q2 24
$-20.1M
$-17.1M
Q1 24
$-45.7M
$-28.2M
Gross Margin
IRTC
IRTC
PD
PD
Q4 25
70.9%
85.3%
Q3 25
71.1%
84.6%
Q2 25
71.2%
84.0%
Q1 25
68.8%
83.6%
Q4 24
70.0%
83.0%
Q3 24
68.8%
82.7%
Q2 24
69.9%
82.6%
Q1 24
66.3%
81.7%
Operating Margin
IRTC
IRTC
PD
PD
Q4 25
1.1%
6.5%
Q3 25
-4.4%
2.9%
Q2 25
-10.0%
-8.6%
Q1 25
-20.5%
-9.6%
Q4 24
-2.5%
-8.7%
Q3 24
-34.1%
-13.8%
Q2 24
-15.5%
-19.5%
Q1 24
-28.9%
-30.1%
Net Margin
IRTC
IRTC
PD
PD
Q4 25
2.7%
129.7%
Q3 25
-2.7%
7.8%
Q2 25
-7.6%
-6.0%
Q1 25
-19.3%
-7.2%
Q4 24
-0.8%
-5.0%
Q3 24
-31.3%
-9.4%
Q2 24
-13.6%
-15.4%
Q1 24
-34.6%
-25.3%
EPS (diluted)
IRTC
IRTC
PD
PD
Q4 25
$0.18
$1.69
Q3 25
$-0.16
$0.10
Q2 25
$-0.44
$-0.07
Q1 25
$-0.97
$-0.12
Q4 24
$-0.03
$-0.07
Q3 24
$-1.48
$-0.14
Q2 24
$-0.65
$-0.26
Q1 24
$-1.47
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
PD
PD
Cash + ST InvestmentsLiquidity on hand
$583.8M
$547.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$320.5M
Total Assets
$1.0B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
PD
PD
Q4 25
$583.8M
$547.8M
Q3 25
$565.2M
$567.9M
Q2 25
$545.5M
$597.1M
Q1 25
$520.6M
$570.8M
Q4 24
$535.6M
$542.2M
Q3 24
$522.0M
$599.3M
Q2 24
$561.5M
$592.8M
Q1 24
$569.1M
$571.2M
Total Debt
IRTC
IRTC
PD
PD
Q4 25
Q3 25
Q2 25
Q1 25
$484.5M
Q4 24
Q3 24
Q2 24
Q1 24
$489.5M
Stockholders' Equity
IRTC
IRTC
PD
PD
Q4 25
$152.7M
$320.5M
Q3 25
$121.9M
$180.7M
Q2 25
$103.7M
$145.7M
Q1 25
$86.7M
$129.8M
Q4 24
$90.9M
$111.6M
Q3 24
$71.8M
$164.7M
Q2 24
$99.2M
$174.0M
Q1 24
$90.3M
$171.6M
Total Assets
IRTC
IRTC
PD
PD
Q4 25
$1.0B
$1.0B
Q3 25
$995.2M
$891.5M
Q2 25
$964.0M
$926.8M
Q1 25
$926.1M
$927.3M
Q4 24
$931.4M
$866.8M
Q3 24
$909.7M
$916.0M
Q2 24
$919.2M
$924.0M
Q1 24
$909.8M
$925.3M
Debt / Equity
IRTC
IRTC
PD
PD
Q4 25
Q3 25
Q2 25
Q1 25
3.73×
Q4 24
Q3 24
Q2 24
Q1 24
2.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
PD
PD
Operating Cash FlowLast quarter
$26.2M
$24.8M
Free Cash FlowOCF − Capex
$14.5M
$24.1M
FCF MarginFCF / Revenue
6.9%
19.3%
Capex IntensityCapex / Revenue
5.6%
0.6%
Cash ConversionOCF / Net Profit
4.70×
0.15×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$117.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
PD
PD
Q4 25
$26.2M
$24.8M
Q3 25
$34.9M
$34.0M
Q2 25
$27.7M
$30.7M
Q1 25
$-7.9M
$31.4M
Q4 24
$19.2M
$22.1M
Q3 24
$24.3M
$35.8M
Q2 24
$11.8M
$28.6M
Q1 24
$-52.0M
$22.2M
Free Cash Flow
IRTC
IRTC
PD
PD
Q4 25
$14.5M
$24.1M
Q3 25
$20.1M
$33.1M
Q2 25
$17.3M
$30.2M
Q1 25
$-17.3M
$30.3M
Q4 24
$12.4M
$21.5M
Q3 24
$15.5M
$35.1M
Q2 24
$3.4M
$28.2M
Q1 24
$-61.8M
$21.2M
FCF Margin
IRTC
IRTC
PD
PD
Q4 25
6.9%
19.3%
Q3 25
10.4%
26.8%
Q2 25
9.3%
25.2%
Q1 25
-10.9%
24.9%
Q4 24
7.5%
18.1%
Q3 24
10.5%
30.3%
Q2 24
2.3%
25.4%
Q1 24
-46.8%
19.1%
Capex Intensity
IRTC
IRTC
PD
PD
Q4 25
5.6%
0.6%
Q3 25
7.7%
0.7%
Q2 25
5.6%
0.4%
Q1 25
5.9%
0.9%
Q4 24
4.2%
0.5%
Q3 24
6.0%
0.5%
Q2 24
5.7%
0.4%
Q1 24
7.4%
0.9%
Cash Conversion
IRTC
IRTC
PD
PD
Q4 25
4.70×
0.15×
Q3 25
3.55×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

PD
PD

US$88.8M71%
Non Us$35.7M29%

Related Comparisons